4 days ago
SYRE
AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 23%
#1194 out of 5254 analysts
Average Return
+31.45%
Win Rate
82%14 out of 17
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +154.75% | $28.66 | $73.01 | 2025-12-01 - 2026-04-17 | Strong Buy |
Sionna Therapeutics IncSION | +101.39% | $21.62 | $43.54 | 2025-09-08 - 2026-04-17 | Strong Buy |
Contineum Therapeutics IncCTNM | +94.12% | $7.14 | $13.86 | 2025-03-13 - 2026-03-12 | Strong Buy |
Armata Pharmaceuticals IncARMP | +81.10% | $6.35 | $11.50 | 2026-01-05 - 2026-04-17 | Strong Buy |
Theravance Biopharma IncTBPH | +62.55% | $10.60 | $17.23 | 2025-06-17 - 2026-04-17 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | 2 | Strong Buy | $95.00 | +30.12% | Maintains | 4 days ago |
Mindwalk Holdings CorpHYFT | 1 | Strong Buy | $5.00 | +275.94% | Initiates Coverage On | 4 days ago |
Abcellera Biologics IncABCL | 1 | Strong Buy | $11.00 | +174.31% | Initiates Coverage On | 11 days ago |
Trevi Therapeutics IncTRVI | 1 | Strong Buy | $24.00 | +57.58% | Maintains | a month ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $29.00 | +93.98% | Upgrades | 2 months ago |
Armata Pharmaceuticals IncARMP | 1 | Strong Buy | $15.00 | +30.43% | Initiates Coverage On | 4 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $46.00 | +5.65% | Initiates Coverage On | 7 months ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $24.00 | +39.29% | Initiates Coverage On | 10 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | +317.31% | Maintains | 10 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | +1,050.44% | Initiates Coverage On | a year ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | N/A | Maintains | a year ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | N/A | Initiates Coverage On | a year ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.